LifeSave Transport Announces Hiring Push for Flight Nurses and Medics

    NEXT STORY
    NMPA Approves Toripalimab in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma after Failure of at Least Two Lines of Prior Systemic Therapy
    PREV STORY
    Iterum Therapeutics to Present in Upcoming Investor Conferences
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    LifeSave Transport Announces Hiring Push for Flight Nurses and Medics

    NEXT STORY
    NMPA Approves Toripalimab in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma after Failure of at Least Two Lines of Prior Systemic Therapy
    PREV STORY
    Iterum Therapeutics to Present in Upcoming Investor Conferences
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BeiGene Initiates Global Head-to-Head Phase 3 Clinical Trial of Zanubrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    CAMBRIDGE, Mass. and BEIJING, China, Nov. 07, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: ...

    author_avatar
    NASDAQ Market News

    Incysus Therapeutics Scientific Co-Founder Lawrence Lamb, PhD to Present at 8th International Gamma-Delta T Cell Conference

    Symposium Title: “Targeting of chemotherapy-induced NKG2DL by localized repetitive γδ T cell infusions: a ...

    author_avatar
    NASDAQ Market News

    Abeona Therapeutics Receives FDA Orphan Drug Designation for EB-101 Gene Therapy Product for Patients with Epidermolysis Bullosa

    Abeona’s Third Gene Therapy Program to Receive FDA Orphan Designation EB-101 Gene Therapy for ...

    author_avatar
    NASDAQ Market News